Activity of clinically relevant antimalarial drugs on plasmodium falciparum mature gametocytes in an atp bioluminescence "transmission blocking" assay

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lelièvre, Joël ^a   Almela, Maria Jesus ^a   Lozano, Sonia ^a   Miguel, Celia ^a   Franco, Virginia ^a,c   Leroy, Didier ^b   Herreros, Esperanza ^a  

^a GLAXOSMITHKLINE   (Spain)

^b Medicines for Malaria Venture   (Switzerland)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIMALARIAL AGENT; ARTESUNATE; ATOVAQUONE; AZITHROMYCIN; BENFLUMETOL; CHLOROQUINE; CYCLOHEXIMIDE; DIHYDROARTEMISININ; EPOXOMICIN; HALOFANTRINE; MEFLOQUINE; METHYLENE BLUE; PRIMAQUINE; PYRIMETHAMINE; PYRONARIDINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; ATP BIOLUMINESCENCE TRANSMISSION BLOCKING ASSAY; BIOLUMINESCENCE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; GAMETOCYTE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG SENSITIVITY; GERM CELL; LUMINESCENCE; METHODOLOGY;

PLASMODIUM FALCIPARUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIMALARIALS; GERM CELLS; LUMINESCENT MEASUREMENTS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 84859728437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035019     Document Type: Article

References (49)

1. Silvestrini F, Bozdech Z, Lanfrancotti A, Di Giulio E, Bultrini E, et al. (2005) Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum. Mol Biochem Parasitol 143: 100-110.
2. Tanaka TQ, Williamson KC, (2011) A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol Biochem Parasitol 177: 160-163.
3. Chevalley S, Coste A, Lopez A, Pipy B, Valentin A, (2010) Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malar J 9: 49.
4. Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, et al. (2011) Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A 108: E1214-1223.
5. Peatey CL, Skinner-Adams TS, Dixon MW, McCarthy JS, Gardiner DL, et al. (2009) Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis 200: 1518-1521.
6. Buchholz K, Burke TA, Williamson KC, Wiegand RC, Wirth DF, et al. (2011) A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis 203: 1445-1453.
7. Vanderberg JP, Weiss MM, Mack SR, (1977) In vitro cultivation of the sporogonic stages of Plasmodium: a review. Bull World Health Organ 55: 377-392.
8. Ifediba T, Vanderberg JP, (1981) Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294: 364-366.
9. Gupta SK, Schulman S, Vanderberg JP, (1985) Stage-dependent toxicity of N-acetyl-glucosamine to Plasmodium falciparum. J Protozool 32: 91-95.
10. Mann VH, Law MH, Watters D, Saul A, (1996) The effects of bistratene A on the development of Plasmodium falciparum in culture. Int J Parasitol 26: 117-121.
11. Fivelman QL, McRobert L, Sharp S, Taylor CJ, Saeed M, et al. (2007) Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Mol Biochem Parasitol 154: 119-123.
12. Squatrito RC, Connor JP, Buller RE, (1995) Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. Gynecol Oncol 58: 101-105.
13. Crouch SP, Kozlowski R, Slater KJ, Fletcher J, (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160: 81-88.
14. Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL, (2011) A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol Biochem Parasitol.
15. Talman AM, Blagborough AM, Sinden RE, (2010) A Plasmodium falciparum strain expressing GFP throughout the parasite's life-cycle. PLoS One 5: e9156.
16. Moore LR, Fujioka H, Williams PS, Chalmers JJ, Grimberg B, et al. (2006) Hemoglobin degradation in malaria-infected erythrocytes determined from live cell magnetophoresis. Faseb J 20: 747-749.
17. Zhang JH, Chung TD, Oldenburg KR, (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73.
18. Czesny B, Goshu S, Cook JL, Williamson KC, (2009) The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrob Agents Chemother 53: 4080-4085.
19. Benoit-Vical F, Lelievre J, Berry A, Deymier C, Dechy-Cabaret O, et al. (2007) Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother 51: 1463-1472.
20. Chotivanich K, Sattabongkot J, Udomsangpetch R, Looareesuwan S, Day NP, et al. (2006) Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother 50: 1927-1930.
21. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, et al. (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 9-17.
22. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658.
23. Lanners HN, (1991) Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitol Res 77: 478-481.
24. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, et al. (2004) Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 48: 1329-1334.
25. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, et al. (1968) Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 38: 625-632.
26. Smalley ME, Sinden RE, (1977) Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74: 1-8.
27. Akoachere M, Buchholz K, Fischer E, Burhenne J, Haefeli WE, et al. (2005) In vitro assessment of methylene blue on chloroquine-sensitive and-resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob Agents Chemother 49: 4592-4597.
28. Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, et al. (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One 4: e5318.
29. Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM, et al. (1998) Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob Agents Chemother 42: 682-686.
30. Mungthin M, Bray PG, Ridley RG, Ward SA, (1998) Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob Agents Chemother 42: 2973-2977.
31. Hoppe HC, van Schalkwyk DA, Wiehart UI, Meredith SA, Egan J, et al. (2004) Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Antimicrob Agents Chemother 48: 2370-2378.
32. Basco LK, Gillotin C, Gimenez F, Farinotti R, Le Bras J, (1992) In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br J Clin Pharmacol 33: 517-520.
33. Ringwald P, Bickii J, Basco LK, (1996) In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 55: 254-258.
34. Souri E, Nateghpour M, Farsam H, Kaji Z, Hamedi Y, et al. (2002) In Vitro Activity of Mefloquine and its Enantiomers Against Plasmodium falciparum. Iran J Pharmacol & Therapeutics pp. 17-19.
35. Basco LK, Le Bras J, (1992) In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 47: 521-527.
36. O'Neill PM, Mukhtar A, Stocks PA, Randle LE, Hindley S, et al. (2003) Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. J Med Chem 46: 4933-4945.
37. Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, et al. (2012) The Activities of Current Antimalarial Drugs on Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites. PLoS Medicine [accepted for publication].
38. Kurth F, Pongratz P, Belard S, Mordmuller B, Kremsner PG, et al. (2009) In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Malar J 8: 79.
39. Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Wilairat P, (2000) Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Parasitol Int 48: 275-280.
40. Butcher GA, Sinden RE, (2003) Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. Am J Trop Med Hyg 68: 111-114.
41. Butcher GA, (1997) Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27: 975-987.
42. Ekong RM, Kirby GC, Patel G, Phillipson JD, Warhurst DC, (1990) Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis. Biochem Pharmacol 40: 297-301.
43. Sinden RE, Smalley ME, (1979) Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology 79: 277-296.
44. Biswas S, (2001) In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. J Postgrad Med 47: 240-243.
45. Shimizu S, Osada Y, Kanazawa T, Tanaka Y, Arai M, (2010) Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication. Malar J 9: 73.
46. Bregani ER, Tien TV, Monzani V, Figini G, Manenti F, (2000) Azithromycin in the treatment of Plasmodium falciparum gametocytes. Preliminary observation. Panminerva Med 42: 197-199.
47. Trager W, Jensen JB, (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
48. van Huyssen W, Rieckmann KH, (1993) Disposable environmental chamber for assessing the drug susceptibility of malaria parasites. Trop Med Parasitol 44: 329-330.
49. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.